Aromatase inhibitor treatment for breast cancer: short-term effect on bone health.

Journal: Contemporary oncology (Poznan, Poland)
Published Date: Aug 7, 2015

Abstract

AIM OF THIS STUDY: Aim of this study was to examine the effects of aromatase inhibitors (AIs), which are used in every phase of breast cancer treatment, on the bone mineral density (BMD) of patients with early-stage breast cancer.

Authors

  • Gökhan Erbağ
    Department of Internal Medicine, Faculty Of Medicine, Kocaeli University, Kocaeli, Turkey.
  • Kazım Uygun
    Department of Oncology, Faculty Of Medicine, Kocaeli University, Kocaeli, Turkey.
  • Emine Binnetoğlu
    Department of Internal Medicine, Faculty Of Medicine, Kocaeli University, Kocaeli, Turkey.
  • Ayşe Nurdan Korkmaz
    Department of Nuclear Medicine, Kocaeli State Hospital, Kocaeli, Turkey.
  • Mehmet Aşık
    Department of Internal Medicine, Faculty Of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.
  • Hacer Şen
    Department of Internal Medicine, Faculty Of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.
  • Fahri Güneş
    Department of Internal Medicine, Faculty Of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.
  • Mustafa Eroğlu
    Department of Internal Medicine, Faculty Of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.
  • Ferhat Gökmen
    Department of Physical Therapy and Rehabilitation, Faculty of Medicine, Çanakkale Onsekiz Mart University, Çanakkale, Turkey.
  • Süleyman Temiz
    Department of Oncology, Faculty Of Medicine, Kocaeli University, Kocaeli, Turkey.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals